{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:00:28Z","timestamp":1770134428131,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.eplepsyres.2003.08.010","type":"journal-article","created":{"date-parts":[[2003,10,29]],"date-time":"2003-10-29T17:21:11Z","timestamp":1067448071000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Tolerability of levetiracetam in elderly patients with CNS disorders"],"prefix":"10.1016","volume":"56","author":[{"given":"Joyce A","family":"Cramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilo E","family":"Leppik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien De","family":"Rue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Edrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2003.08.010_BIB1","first-page":"99","article-title":"Levetiracetam reduces caffeine-induced intracellular calcium transients in rat cultured hippocampal neurons","volume":"43","author":"Angehagen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/j.1552-4604.2000.tb05984.x","article-title":"Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique","volume":"40","author":"Browne","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archfami.3.7.589","article-title":"Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics","volume":"3","author":"Cloyd","year":"1994","journal-title":"Arch Fam. Med."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB4","unstructured":"COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms. U.S. Food and Drug Administration, 1997."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","article-title":"Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid","volume":"44","author":"Coupez","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-1211(01)00286-8","article-title":"Treatment options for refractory epilepsy: new medications and vagal nerve stimulation","volume":"47","author":"Cramer","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00003495-200060040-00004","article-title":"Levetiracetam","volume":"60","author":"Dooley","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0749-0690(18)30616-5","article-title":"Altered pharmacodynamics in the elderly","volume":"6","author":"Feely","year":"1990","journal-title":"Clin. Geriatr. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2003.08.010_BIB10","first-page":"A144","article-title":"Levetiracetam in patients aged \u226565 years: a subset of the Keeper\u2122 trial","volume":"6","author":"Ferrendelli","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-200060040-00006","volume":"60","author":"Figgitt","year":"2000","journal-title":"Drugs"},{"issue":"Suppl. 3","key":"10.1016\/j.eplepsyres.2003.08.010_BIB12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1528-1157.2001.042suppl.3055.x","article-title":"Epilepsy in the elderly: some clinical and pharmaco-therapeutic aspects","volume":"42","author":"Kr\u00e4mer","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2003.08.010_BIB13","first-page":"142","article-title":"Levetiracetam in elderly patients with epilepsy","volume":"42","author":"Kr\u00e4mer","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1528-1157.1998.tb01294.x","article-title":"Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use","volume":"39","author":"Lackner","year":"1998","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2003.08.010_BIB15","first-page":"S221","article-title":"Treatment of epilepsy in 3 specialized populations","volume":"7","author":"Leppik","year":"2001","journal-title":"Am. J. Managed Care"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB16","unstructured":"Leppik, I.E., Worff, D., 1997. Drug interactions in the elderly with epilepsy. In: Rowan, A.J., Ramsay, R.E., (Eds.), Seizures and Epilepsy in the Elderly. Butterworth-Heinemann, Boston, pp. 291\u2013302."},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2003.08.010_BIB17","first-page":"240","article-title":"Effective levetiracetam doses and serum concentrations: age effects","volume":"43","author":"Leppik","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-1211(01)00253-4","article-title":"Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers","volume":"46","author":"Levy","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyonetz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-9556(24)15285-3","article-title":"In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic drug","volume":"27","author":"Nicolas","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-1211(01)00293-5","article-title":"Lack of effect of repeated administration of levetiracetam on the pharmacokinetic and pharmacodynamic profiles of warfarin","volume":"47","author":"Ragueneau-Majlessi","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00004714-200002000-00004","article-title":"A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder","volume":"20","author":"Rickels","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/geronj\/31.2.155","article-title":"The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study","volume":"31","author":"Rowe","year":"1976","journal-title":"J. Gerontol."},{"issue":"Suppl. 7","key":"10.1016\/j.eplepsyres.2003.08.010_BIB26","first-page":"104","article-title":"Predictor of serious adverse events from antiepileptic drug therapy in epilepsy patients 60 years and older","volume":"40","author":"Sirven","year":"1999","journal-title":"Epilepsia"},{"issue":"Suppl. 11","key":"10.1016\/j.eplepsyres.2003.08.010_BIB27","first-page":"24","article-title":"Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety","volume":"58","author":"Small","year":"1997","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB28","unstructured":"White, J.R., Walczak, T., Leppik, I.E., Rarick, J., Tran, T., Beniak, T.E., Gumnit, R.J., in press. Discontinuation of Levetiracetam due to Behavioral Reasons: A Case Control Study."},{"key":"10.1016\/j.eplepsyres.2003.08.010_BIB29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00003088-198815050-00002","article-title":"Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly","volume":"15","author":"Woodhouse","year":"1988","journal-title":"Clin. Pharmacokinetics"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012110300158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092012110300158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:13:40Z","timestamp":1760274820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012110300158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S092012110300158X"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2003.08.010","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability of levetiracetam in elderly patients with CNS disorders","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2003.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}